Inventor · disambiguated record
Mirco Meniconi
Also filed as: MENICONI MIRCO
8 granted patents·3 pending applications·15 citations·filing 2008–2022
80Inventor score
Files withPADLOCK THERAPEUTICS INC6CANCER RESEARCH TECH LTD2GLAXO GROUP LTD1MONTE ROSA THERAPEUTICS AG1QUARTET MEDICINE INC1
Top patents by PatentIndex Score
11 records- 0186US11512095B2BCL6 inhibitorsCANCER RESEARCH TECH LTD·Filed 2019·Granted Nov 29, 2022·7 cites·20 claims
- 0278US11198681B2Heteroaryl inhibitors of PAD4PADLOCK THERAPEUTICS INC·Filed 2017·Granted Dec 14, 2021·4 cites·15 claims
- 0371US11026937B2Heteroaryl inhibitors of PAD4PADLOCK THERAPEUTICS INC·Filed 2017·Granted Jun 8, 2021·1 cites·7 claims
- 0470US9963448B2Bicyclic inhibitors of PAD4PADLOCK THERAPEUTICS INC·Filed 2016·Granted May 8, 2018·2 cites·20 claims
- 0569US12486285B2BCL6 inhibitorsCANCER RESEARCH TECH LTD·Filed 2022·Granted Dec 2, 2025·0 cites·22 claims
- 0668US10703741B2Covalent inhibitors of PAD4PADLOCK THERAPEUTICS INC·Filed 2017·Granted Jul 7, 2020·1 cites·13 claims
- 0762US11897866B2Heteroaryl inhibitors of PAD4PADLOCK THERAPEUTICS INC·Filed 2021·Granted Feb 13, 2024·0 cites·15 claims
- 0860US2021299115A1Heteroaryl inhibitors of pad4PADLOCK THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0953US2022242846A1Isoindolinone compoundsMONTE ROSA THERAPEUTICS AG·Filed 2022·Application pending·0 cites
- 1041US2010197699A1I-OXA-3-Azaspiro (4.5) Decan-2-One And 1-OXA-3, 8-Diazaspiro (4.5) Decan-2-One Derivatives For The Treatment of Eating DisordersGLAXO GROUP LTD·Filed 2008·Application pending·0 cites
- 1129US9963462B2Sepiapterin reductase inhibitorsQUARTET MEDICINE INC·Filed 2016·Granted May 8, 2018·0 cites·27 claims
Join the waitlist — get patent alerts
Get an alert when Mirco Meniconi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →